Sentinel node localization: Do or dye alone?

British Journal of Radiology

Volumn 74, Issue 882, 2001, Pages 475-477

  Allan, R ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLOID TC 99M; DYE;

CANCER STAGING; CLINICAL TRIAL; EXCISION; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MELANOMA; NOTE; OCCULT CANCER; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; THEORY; TREATMENT OUTCOME;

EID: 0034926314     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.74.882.740475     Document Type: Note

References (10)

1. An approach for the treatment of penile carcinoma
2. Technical details of intraoperative lymphatic mapping for early malignant melanoma
3. Efficacy of an elective lymph node dissection of 1-4 mm thick melanomas for patients 60 years of age and younger
4. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial
5. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
6. WHO declares lymphatic mapping to be the standard of care for melanoma
7. Investment in new technology research can save future health care dollars
8. Sentinel lymph node biopsy in malignant melanoma: A series of 100 consecutive patients
9. What is a prognosis worth?
10. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy